Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

54.27
+3.717.34%
Post-market: 55.421.15+2.12%19:57 EDT
Volume:5.56M
Turnover:305.32M
Market Cap:8.31B
PE:19.60
High:56.87
Open:51.10
Low:49.97
Close:50.56
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:3.94
T/O Rate:3.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:13.75
PE(LYR):19.59

Loading ...

TG Therapeutics (TGTX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jul 13

TG Therapeutics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 13

Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says

MT Newswires Live
·
Jul 07

BofA Securities Adjusts Price Target on TG Therapeutics to $20 From $17, Maintains Underperform Rating

MT Newswires Live
·
Jul 07

TG Therapeutics price target raised to $20 from $17 at BofA

TIPRANKS
·
Jul 07

TG Therapeutics Price Target Maintained with a $70.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 07

TG Therapeutics: Buy Rating Reaffirmed as Briumvi Schizophrenia Trial Adds Upside Optionality; $70 Price Target Unchanged

TIPRANKS
·
Jul 06

TG Therapeutics initiates Briumvi clinical trial

TIPRANKS
·
Jul 06

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating Briumvi in Patients with Treatment-resistant Schizophrenia

THOMSON REUTERS
·
Jul 06

TG Therapeutics (TGTX) Gains Momentum As The Fair Value Narrative Turns More Cautious

Simply Wall St.
·
Jun 26

TG Therapeutics price target raised to $83 from $57 at Jefferies

TIPRANKS
·
Jun 23

Movement Alert|TG Therapeutics Rises 6.88% in Regular Trading, Trading at $56.5

Market Focus
·
Jun 22

Jefferies Reaffirms Their Buy Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Jun 22

TG Therapeutics Stock Rises Thursday: What's Driving The Gains?

Benzinga_recent_news
·
Jun 19

TG Therapeutics Shareholders Reject Executive Compensation at Meeting

TIPRANKS
·
Jun 13

TG Therapeutics shareholders reject executive pay proposal at annual meeting

Reuters
·
Jun 13

A Look At TG Therapeutics (TGTX) Valuation After Fresh BRIUMVI Clinical And Formulation Milestones

Simply Wall St.
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

TG Therapeutics: Buy Rating Reiterated on Briumvi Expansion Strategy, $70 Price Target Unchanged

TIPRANKS
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09